These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19122313)

  • 1. Design and synthesis of piperazinylpyridine derivatives as novel 5-HT1A agonists/5-HT3 antagonists for the treatment of irritable bowel syndrome (IBS).
    Asagarasu A; Matsui T; Hayashi H; Tamaoki S; Yamauchi Y; Sato M
    Chem Pharm Bull (Tokyo); 2009 Jan; 57(1):34-42. PubMed ID: 19122313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.
    Asagarasu A; Matsui T; Hayashi H; Tamaoki S; Yamauchi Y; Minato K; Sato M
    J Med Chem; 2010 Nov; 53(21):7549-63. PubMed ID: 20931963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of 3-amino-5,6,7,8-tetrahydro-2-[4-[4-(quinolin-2-yl)piperazin-1-yl]butyl]quinazolin-4(3H)-one (TZB-30878), a novel therapeutic agent for diarrhea-predominant irritable bowel syndrome (IBS) and its effects on an experimental IBS model.
    Tamaoki S; Yamauchi Y; Nakano Y; Sakano S; Asagarasu A; Sato M
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1315-23. PubMed ID: 17540858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2,5-Thiadiazole derivatives are potent and selective ligands at human 5-HT1A receptors.
    Sabb AL; Vogel RL; Kelly MG; Palmer Y; Smith DL; Andree TH; Schechter LE
    Bioorg Med Chem Lett; 2001 Apr; 11(8):1069-71. PubMed ID: 11327592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea.
    Chey WD; Cash BD
    Expert Opin Investig Drugs; 2005 Feb; 14(2):185-93. PubMed ID: 15757394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally active benzoxazole derivative as 5-HT3 receptor partial agonist for treatment of diarrhea-predominant irritable bowel syndrome.
    Yoshida S; Shiokawa S; Kawano K; Ito T; Murakami H; Suzuki H; Sato Y
    J Med Chem; 2005 Nov; 48(22):7075-9. PubMed ID: 16250667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.
    Liégeois JF; Deville M; Dilly S; Lamy C; Mangin F; Résimont M; Tarazi FI
    J Med Chem; 2012 Feb; 55(4):1572-82. PubMed ID: 22268448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
    López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
    Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new 5-HT3 receptor ligand. II. Structure-activity analysis of 5-HT3 receptor agonist action in the gut.
    Yamada M; Sato Y; Kobayashi K; Konno F; Soneda T; Watanabe T
    Chem Pharm Bull (Tokyo); 1998 Mar; 46(3):445-51. PubMed ID: 9549886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.
    Manning DD; Cioffi CL; Usyatinsky A; Fitzpatrick K; Masih L; Guo C; Zhang Z; Choo SH; Sikkander MI; Ryan KN; Naginskaya J; Hassler C; Dobritsa S; Wierschke JD; Earley WG; Butler AS; Brady CA; Barnes NM; Cohen ML; Guzzo PR
    Bioorg Med Chem Lett; 2011 Jan; 21(1):58-61. PubMed ID: 21146988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M; Zhang L; Rotondo A; Sun H; Morales M
    Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for irritable bowel syndrome.
    Olden KW
    N Engl J Med; 2004 Mar; 350(12):1261-3; author reply 1261-3. PubMed ID: 15028836
    [No Abstract]   [Full Text] [Related]  

  • 13. New 2-piperazinylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmacological evaluation.
    Orjales A; Mosquera R; Labeaga L; Rodes R
    J Med Chem; 1997 Feb; 40(4):586-93. PubMed ID: 9046349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperazine analogs of naphthyridine-3-carboxamides and indole-2-carboxamides: novel 5-HT3 receptor antagonists with antidepressant-like activity.
    Dhar AK; Mahesh R; Jindal A; Bhatt S
    Arch Pharm (Weinheim); 2015 Jan; 348(1):34-45. PubMed ID: 25581677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT3 receptor as a therapeutic target.
    Thompson AJ; Lummis SC
    Expert Opin Ther Targets; 2007 Apr; 11(4):527-40. PubMed ID: 17373882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotherapeutics and serotonin agonists and antagonists.
    Mertz H
    J Clin Gastroenterol; 2005; 39(5 Suppl 3):S247-50. PubMed ID: 15798492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for irritable bowel syndrome.
    Lacy BE
    N Engl J Med; 2004 Mar; 350(12):1261-3; author reply 1261-3. PubMed ID: 15031865
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and 5-HT3 receptor affinity of new quinolinecarboxylic acid derivatives.
    Orjales A; Alonso-Cires L; López-Tudanca PL; Tapia I; Labeaga L; Mosquera R
    Drug Des Discov; 2000; 16(4):271-9. PubMed ID: 10807033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
    Moskwa A; Boznańska P
    Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity.
    Zhang J; Zhang H; Cai W; Yu L; Zhen X; Zhang A
    Bioorg Med Chem; 2009 Jul; 17(14):4873-80. PubMed ID: 19559623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.